Publicaciones en colaboración con investigadoras/es de Hospital Sierrallana (13)

2021

  1. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278

  2. Clinical and preclinical evidence of somatosensory involvement in amyotrophic lateral sclerosis

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1257-1268

2020

  1. A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262

  2. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage

    Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299

  3. Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis

    Neural Regeneration Research, Vol. 15, Núm. 11, pp. 2043-2044

2019

  1. Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach

    Neural Regeneration Research, Vol. 14, Núm. 2, pp. 193-196

2018

  1. Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis

    Journal of the Neurological Sciences

  2. Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study

    Movement Disorders, Vol. 33, Núm. 11, pp. 1809-1813

  3. Retinoids and amyotrophic lateral sclerosis

    JAMA Neurology

  4. The increasing importance of environmental conditions in amyotrophic lateral sclerosis

    International Journal of Biometeorology, Vol. 62, Núm. 8, pp. 1361-1374

2017

  1. Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics

    Frontiers in Neuroendocrinology, Vol. 45, pp. 25-34

2016

  1. Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos

    Revista de Psiquiatria y Salud Mental

1999

  1. Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease

    Journal of the Neurological Sciences, Vol. 171, Núm. 2, pp. 88-91